Adam Irwin Riker MD FACS
Breast, Melanoma, Surgical Oncology (Other than Breast)
"Professor and Chief, Section of Surgical Oncology,\r\nLouisiana State
Join to View Full Profile
1542 Tulane AveRoom 741New Orleans, LA 70112
Phone+1 504-568-4752
Fax+1 504-568-2726
Are you Dr. Riker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Adam Riker, MD is a general surgeon in New Orleans, Louisiana. He is currently licensed to practice medicine in Louisiana, Alabama, and Wisconsin. He is a "Professor and Chief at Section of Surgical Oncology,\r\nLouisiana State.
Education & Training
Loyola University Medical CenterResidency, Surgery, 1994 - 2002
National Cancer InstituteFellowship, Complex General Surgical Oncology, 1996 - 1999
University of South Florida College of MedicineClass of 1994
Certifications & Licensure
FL State Medical License 2001 - 2026
MD State Medical License 1996 - 2023
LA State Medical License 2008 - 2019- LA State Medical License 2015 - 2019
IL State Medical License 1994 - 2017
AL State Medical License 2006 - 2012
WI State Medical License 2002 - 2007
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations.Shivani B Badve, Emily Kim, Udai S Sibia, Orestes T Borrego, Stephen Vara
Ochsner Journal. 2024-01-01 - 2 citationsImpact of Frailty Upon Surgical Decision-Making for Left-Sided Colon Cancer.Udai S Sibia, Shivani B Badve, Alexandra C Istl, J Robert Klune, Adam I Riker
Ochsner Journal. 2023-01-01 - 8 citationsHospital-Based Same-Day Compared to Overnight-Stay Mastectomy: An American College of Surgeons National Surgical Quality Improvement Program Analysis.Udai S Sibia, John R Klune, Justin J Turcotte, Luther H Holton 3rd, Adam I Riker
Ochsner Journal. 2022-01-01
Press Mentions
Immunotherapy Drug Used as 1st-Line Therapy for Merkel Cell Carcinoma Improved SurvivalFebruary 7th, 2019
Research Providing Promising New Treatments for MelanomaDecember 7th, 2016
Cancer Crusaders Hears from LSU Section ChiefNovember 30th, 2016
